Popular:
BioLife Solutions, Inc. (BLFS)
Intrinsic Value
DCF Not Suitable for BLFS
Revenue ($74M) below $1B threshold — insufficient business scale for DCF.
Alternative Approach:
Use EV/Sales vs. industry peers for growth-stage companies.
BioLife Solutions, Inc. (BLFS) Intrinsic Value
DCF-based fair value calculation with Bear, Base, and Bull scenarios
Frequently Asked Questions
Is BLFS stock undervalued or overvalued?
Insufficient data to compute DCF valuation for BLFS. This typically occurs with negative FCF, early-stage companies, or financials where standard DCF models require modification.
What is BLFS's intrinsic value?
Unable to calculate intrinsic value. DCF requires positive free cash flow and complete financial data. For banks/REITs, we substitute Net Income or FFO respectively.
How is BLFS's fair value calculated?
Standard two-stage DCF with 5-year explicit forecast period and Gordon Growth terminal value. WACC estimated from sector averages and company beta. For BLFS, insufficient data prevents full calculation—typically requires 3+ years of positive FCF history.